REYON Pharmaceutical Co., Ltd. (KRX:102460)

South Korea flag South Korea · Delayed Price · Currency is KRW
10,780
+10 (0.09%)
Dec 30, 2025, 3:30 PM KST
-14.17%
Market Cap197.72B
Revenue (ttm)149.34B
Net Income (ttm)-14.25B
Shares Out18.34M
EPS (ttm)-773.90
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume10,882
Average Volume42,287
Open10,630
Previous Close10,770
Day's Range10,630 - 10,870
52-Week Range9,830 - 14,430
Beta0.54
RSI38.54
Earnings DateFeb 13, 2026

About REYON Pharmaceutical

REYON Pharmaceutical Co., Ltd. manufactures and sells medicines. The company offers its products under the areas of adrenal corticosteroides; angiotensin II receptor antagonists; antibiotics; anticholinergics; antiemetic; antihypertensives; anti-inflammatory enzymes; antilipidemic, antirheumatic, and oral hypoglycemic agents; anti-peptic ulcer; antispasmodics; benign prostatic hypertrophy; cough and cold remedies; cardiac stimulant; genitourinary smooth muscle relaxants; hemostatics; immunosuppressants; rheumatoid arthritis; local anesthetics; ... [Read more]

Sector Healthcare
Founded 1955
Employees 440
Stock Exchange Korea Stock Exchange
Ticker Symbol 102460
Full Company Profile

Financial Performance

In 2024, REYON Pharmaceutical's revenue was 148.30 billion, a decrease of -1.83% compared to the previous year's 151.07 billion. Earnings were 4.15 billion, an increase of 15.85%.

Financial Statements

News

There is no news available yet.